Voltage-gated sodium channels (NaCh) are important modulators of membrane
potential and are essential for the action potential in nerve and muscle.
At least two mammalian gene subfamilies exist, the first of which encodes
the well characterized neuronal (brain types I-III), cardiac, and skeletal
muscle isoforms. The second subfamily has only recently been discovered
and contains one well characterized member (designated hNav2.1 in human
and mNav2.3 in mouse) that is probably most commonly expressed in glial
cells associated with peripheral nerve in heart, uterus, and lung. This
channel is absent from the uterine myocyte surface in virgin and early
pregnancy uterus. However, it is expressed at high levels in uterine
smooth muscle at late pregnancy and then disappears from the myocyte cell
surface within several days after delivery. This transient expression on
the uterine myocyte surface strongly suggests that this protein plays
either a delect or permissive role in uterine contraction at term. This
proposal will further expand our understanding of the physiological role
of the hNav2.1/mNav2.3 channels by 1) determining the cell specificity of
protein expression in the fetal and adult mouse and human near term
uterus, 2) determining the subunit composition of the channel in term
uterus, 3) studying channel function using either heterologously expressed
cDNA clones or uterine myocytes, and 4) characterizing the mouse Nav2.3
gene. Goals 1 and 4 are necessary prior to proceeding with a future gene
deletion experiment in a transgenic mouse. These research efforts will
further our understanding of a protein which is important in the
regulation of uterine contractility. Knowledge gained through this study
will provide the necessary background for the development of improved
drugs for regulating uterine contraction, understanding uterine gene and
protein regulation during pregnancy, and analysis of the physiological
consequences of deleting the Nav2.3 gene from a transgenic mouse. In
addition, due to the atypical amino sequence in functionally important
regions of the 2.1/2.3 channels, this NaCh isoform promises to greatly
increase our understanding of voltage-gated sodium channel structure
function relationships.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
785979618
UEI
LT9CXX8L19G1
Project Start Date
01-June-1996
Project End Date
31-May-1999
Budget Start Date
01-July-1997
Budget End Date
31-May-1998
Project Funding Information for 1997
Total Funding
$168,929
Direct Costs
$117,119
Indirect Costs
$51,810
Year
Funding IC
FY Total Cost by IC
1997
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$168,929
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R01HD033515-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01HD033515-02
Patents
No Patents information available for 7R01HD033515-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01HD033515-02
Clinical Studies
No Clinical Studies information available for 7R01HD033515-02
News and More
Related News Releases
No news release information available for 7R01HD033515-02
History
No Historical information available for 7R01HD033515-02
Similar Projects
No Similar Projects information available for 7R01HD033515-02